| Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist | Science advances |  | | 2021 | 271 | 520 |
|
| CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties | Biochimica et Biophysica Acta - General Subjects | | | 2020 | 315 | 272 |
|
| Rapid and low-cost multiplex synthesis of chemokine analogs | Journal of Biological Chemistry |  | | 2018 | 429 | 2 |
|
| Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage | AIDS Research and Human Retroviruses | | | 2017 | 408 | 0 |
|
| Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display | Methods in enzymology | | | 2016 | 582 | 5 |
|
| A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris | Protein expression and purification | | | 2016 | 594 | 362 |
|
| Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | | | 2016 | 692 | 427 |
|
| The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? | PloS one | | | 2015 | 571 | 418 |
|
| Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles | Bioconjugate chemistry |  | | 2011 | 666 | 0 |
|
| Chemokine analogues show suitable stability for development as microbicides | Journal of acquired immune deficiency syndromes | | | 2008 | 629 | 2 |
|
| Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | | | 2008 | 688 | 8 |
|
| Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide | Proceedings of the National Academy of Sciences of the United States of America | | | 2008 | 630 | 2 |
|
| Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | | | 2004 | 725 | 1 |
|
| Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines | Journal of virology | | | 2003 | 567 | 405 |
|
